International Biotechnology (LON:IBT) Announces Earnings Results

International Biotechnology (LON:IBT) announced its quarterly earnings data on Tuesday. The company reported GBX (5.60) (($0.07)) earnings per share for the quarter, Digital Look Earnings reports. International Biotechnology had a net margin of 90.66% and a return on equity of 13.67%.

International Biotechnology Price Performance

LON:IBT opened at GBX 571.98 ($7.61) on Wednesday. The company has a market capitalization of £205.46 million, a price-to-earnings ratio of 5.46 and a beta of 0.21. International Biotechnology has a 1-year low of GBX 480 ($6.39) and a 1-year high of GBX 736 ($9.80). The business has a 50 day moving average of GBX 592.27 and a 200 day moving average of GBX 661.85.

Insiders Place Their Bets

In other news, insider Katherine Cornish-Bowden acquired 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 13th. The stock was purchased at an average cost of GBX 585 ($7.79) per share, for a total transaction of £11,700 ($15,570.93). Also, insider Alexa Henderson bought 6,996 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The shares were acquired at an average price of GBX 711 ($9.46) per share, for a total transaction of £49,741.56 ($66,198.51). Corporate insiders own 4.18% of the company’s stock.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.